课题基金 / 基金详情

Molecular mechanisms of postnatal angiogenesis and neurogenesis

Molecular mechanisms of postnatal angiogenesis and neurogenesis
出生后血管生成和神经发生的分子机制
批准号:
23249020
负责人:
TAKAHASHI Masahide
金额:
$31.12万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31

项目摘要

项目成果

TAKAHASHI Masahide的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To identify the cellular population responsible for the phenotype of girdin KO mice, newly generated girdin flox mice were crossed with nestin-promoter driven Cre-transgenic mice to obtain girdin conditional knockout mice.Our findings suggested that girdin expression in nestin cell lineage is responsible for the phenotype of girdin KO mice.We used a mouse model of pathological ocular neovascularization: oxygen-induced retinopathy.Pathological neovascularization was decreased in S1416A knockin mice. The results demonstrate that girdin and its phosphorylation play an important role in neonatal vascular development and in pathological neovascularization in the retina.We also found that depletion of girdin attenuated venous smooth muscle cells migration and proliferation in vitro and intimal hyperplasia in vein grafts in vivo.Moreover, we demonstrated that a girdin family protein, Dishevelled-associating protein Daple, controls the non-canonical Wnt/Rac pathway and cell motility
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0036681
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Ohara K, Enomoto A, Kato T, Hashimoto T, Isotani-Sakakibara M, Asai N, Ishida-Takagishi M, Weng L, Nakayama M, Watanabe T, Kato K, Kaibuchi K, Murakumo Y, Hirooka Y, Goto H, Takahashi M]
通讯作者: Takahashi M
Aktの基質蛋白Girdinのがんの進展、血管新生における役割
Akt 底物蛋白 Girdin 在癌症进展和血管生成中的作用
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Nakayama T, Kurobe H, Sugasawa N, Kinoshita H, Higashida M, Matsuoka Y, Yoshida Y, Hirata Y, Sakata M, Maxfield M, Shimabukuro M, Takahama Y, Sata M, Tamaki T, Kitagawa T, Tomita S., Kazuhisa Sekimizu, Nakanishi K., 児谷吉紘,西村伸一,珠玖隆行, 高橋雅英]
通讯作者: 高橋雅英
DOI: 10.1161/circresaha.110.236174
发表时间: 2011-05-13
期刊: CIRCULATION RESEARCH
影响因子: 20.1
作者: [Miyake, Hiroshi, Maeda, Kengo, Murohara, Toyoaki]
通讯作者: Murohara, Toyoaki
Girdin is an intrinsic regulator of neuroblast chain migation in the Rostral migratory stream of the postnatal brain
Girdin 是出生后大脑头端迁移流中神经母细胞链迁移的内在调节因子
DOI: --
发表时间: 2011
期刊: Journal of Neuroscience
影响因子: 5.3
作者: [Okazaki, K., Y. Kuroda, K. Taguchi, H. Takahashi, N. Koga and S. Ikeda, Yun Wang]
通讯作者: Yun Wang
20
    Mechanism of chemoresistance by HDAC1-associating protein and development of molecular targeted therapy
    • 批准号:
      24650618
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      TAKAHASHI Masahide
    • 依托单位:
    Enhanced photoresponse in organically-modified oxo alternating copolymers
    • 批准号:
      22360276
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2010
    • 负责人:
      TAKAHASHI Masahide
    • 依托单位:
    Organic-inorganic hybrid films with photo and stimuli responsive micro structures
    • 批准号:
      22655071
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.23万
    • 财政年份:
      2010
    • 负责人:
      TAKAHASHI Masahide
    • 依托单位:
    Physiological functions of the Akt substrate Girdin and its family proteins and their roles in pathogenesis
    • 批准号:
      19209013
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.7万
    • 财政年份:
      2007
    • 负责人:
      TAKAHASHI Masahide
    • 依托单位:
    国内基金
    海外基金
    NCAPD2通过PI3K-AKT-mTOR-Myc信号轴促进子宫内膜样癌增殖及EMT的机制与靶向治疗研究
    • 批准号:
      JCZRLH202600400
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于“痞积转化”理论探究网果酸模通过PI3K/Akt通路调控巨噬细胞极化平衡抑制胃癌的分子机制​
    “补肾健脾,化痰通络”法调控PI3K/Akt/MCT1介导的乳酸转运改善血管性痴呆的机制研究
    当归芍药散经TrkB/Akt通路调节AD中枢葡萄糖代谢的认知保护机制研究
    • 批准号:
      2026JJ60631
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王亚晗
    • 依托单位: